Maravai LifeSciences Q3 2024 Earnings Call Transcript

MRVI Stock  USD 1.98  0.09  4.35%   
Under 61% of Maravai Lifesciences' investor base is looking to short. The analysis of overall sentiment of trading Maravai Lifesciences Holdings stock suggests that many investors are alarmed at this time. Maravai Lifesciences' investing sentiment shows overall attitude of investors towards Maravai Lifesciences Holdings.
MRVI earnings call for the period ending September 30, 2024.

Read at fool.com
fool News
  

Maravai Lifesciences Fundamental Analysis

We analyze Maravai Lifesciences' financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Maravai Lifesciences using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Maravai Lifesciences based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Price To Book

Price To Book Comparative Analysis

Maravai Lifesciences is currently under evaluation in price to book category among its peers. Price to Book (P/B) ratio is used to relate a company book value to its current market price. A high P/B ratio indicates that investors expect executives to generate more returns on their investments from a given set of assets. Book value is the accounting value of assets minus liabilities.

Maravai Lifesciences Potential Pair-trading

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Maravai Lifesciences stock to make a market-neutral strategy. Peer analysis of Maravai Lifesciences could also be used in its relative valuation, which is a method of valuing Maravai Lifesciences by comparing valuation metrics with similar companies.

Peers

Maravai Lifesciences Related Equities

ALECAlector   12.50   
0%
100.0%
ARQTArcutis Biotherapeutics   0.07   
0%
1.0%
HRMYHarmony Biosciences   0.12   
1.0%
0%
DNLIDenali Therapeutics   0.42   
3.0%
0%
LEGNLegend Biotech   0.81   
6.0%
0%
EWTXEdgewise Therapeutics   0.82   
6.0%
0%
INSMInsmed   0.84   
6.0%
0%
INCYIncyte   1.26   
10.0%
0%
FOLDAmicus Therapeutics   1.64   
13.0%
0%
IMVTImmunovant   1.96   
15.0%
0%
PTGXProtagonist Therapeutics   2.16   
17.0%
0%
CYTKCytokinetics   2.40   
19.0%
0%
RAREUltragenyx   2.42   
19.0%
0%
AGIOAgios Pharm   2.57   
20.0%
0%
HALOHalozyme Therapeutics   2.75   
22.0%
0%
APLSApellis Pharmaceuticals   2.86   
22.0%
0%
ARGXArgenx NV   3.42   
27.0%
0%
ROIVRoivant Sciences   3.54   
28.0%
0%
KRYSKrystal Biotech   3.64   
29.0%
0%
ASNDAscendis Pharma   5.11   
40.0%
0%
AKROAkero Therapeutics   5.99   
47.0%
0%

Complementary Tools for Maravai Stock analysis

When running Maravai Lifesciences' price analysis, check to measure Maravai Lifesciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Maravai Lifesciences is operating at the current time. Most of Maravai Lifesciences' value examination focuses on studying past and present price action to predict the probability of Maravai Lifesciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Maravai Lifesciences' price. Additionally, you may evaluate how the addition of Maravai Lifesciences to your portfolios can decrease your overall portfolio volatility.
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
AI Portfolio Architect
Use AI to generate optimal portfolios and find profitable investment opportunities